Early research (Phase 1)Study completedNCT01536145What this trial is testingCP-751,871 Treatment For Patients With Multiple MyelomaWho this might be right forMultiple Myeloma Pfizer 47
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07336472What this trial is testingIBI3003 in Subjects With Relapsed or Refractory Multiple MyelomaWho this might be right forMultiple Myeloma Fortvita Biologics (USA)Inc. 360
Early research (Phase 1)Active Not RecruitingNCT04555551What this trial is testingMCARH109 Chimeric Antigen Receptor (CAR) Modified T Cells for the Treatment of Multiple MyelomaWho this might be right forMultiple Myeloma Memorial Sloan Kettering Cancer Center 17
Large-scale testing (Phase 3)Study completedNCT00002850What this trial is testingAntibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving ChemotherapyWho this might be right forInfectionMultiple Myeloma Gary Morrow 212
Early research (Phase 1)Study completedNCT00569283What this trial is testingDonor Natural Killer Cell Infusion in Preventing Relapse or Graft Failure in Patients Who Have Undergone Donor Bone Marrow TransplantWho this might be right forCancer Asan Medical Center 18
Early research (Phase 1)Study completedNCT00562224What this trial is testingStudy of the Safety and Tolerability of Oral Capsule Form of PCI-24781 in Advanced Cancer PatientsWho this might be right forNeoplasms by SiteLymphoma, Non-hodgkinHodgkin Disease+2 more Pharmacyclics LLC. 36
Large-scale testing (Phase 3)Study completedNCT00003805What this trial is testingPrevention of Infection in Patients With Hematologic Cancer and Persistent Fever Caused by a Low White Blood Cell CountWho this might be right forBone Marrow SuppressionFever, Sweats, and Hot FlashesInfection+6 more European Organisation for Research and Treatment of Cancer - EORTC 859
Testing effectiveness (Phase 2)Looking for participantsNCT05092451What this trial is testingPhase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Hematological MalignancesWho this might be right forB-Cell LymphomaMyelodysplastic Syndromes (MDS)Acute Myeloid Leukemia (AML)+7 more M.D. Anderson Cancer Center 80
Early research (Phase 1)Study completedNCT00054483What this trial is testingBortezomib in Treating Patients With Advanced Cancer and Kidney DysfunctionWho this might be right forAdult Grade III Lymphomatoid GranulomatosisAdult Nasal Type Extranodal NK/T-cell LymphomaExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue+31 more National Cancer Institute (NCI) 69
Testing effectiveness (Phase 2)Study completedNCT00948961What this trial is testingCDX-1401 in Patients With Malignancies Known to Express NY-ESO-1Who this might be right forAdvanced Malignancies Celldex Therapeutics 70
Testing effectiveness (Phase 2)UnknownNCT00389701What this trial is testingBortezomib and Dexamethasone in Treating Patients With Multiple Myeloma That Has Relapsed or Has Not Responded to TreatmentWho this might be right forMultiple Myeloma and Plasma Cell Neoplasm Sparrow Regional Cancer Center 30
Early research (Phase 1)Not Yet RecruitingNCT06500507What this trial is testingQLS4131 in Patients With Recurrent or Refractory Multiple MyelomaWho this might be right forRelapsed or Refractory Multiple Myeloma Qilu Pharmaceutical Co., Ltd. 90
Testing effectiveness (Phase 2)Looking for participantsNCT06105554What this trial is testingPhase I/II Open Label Study of Belumosudil Mesylate Alone, and in Combination With Dexamethasone, in Patients With Relapsed/Refractory Multiple MyelomaWho this might be right forMultiple Myeloma M.D. Anderson Cancer Center 36
Testing effectiveness (Phase 2)Study completedNCT03544281What this trial is testingTo Evaluate Safety, Tolerability, and Clinical Activity of the Antibody-drug Conjugate, GSK2857916 Administered in Combination With Lenalidomide Plus Dexamethasone (Arm A), or in Combination With Bortezomib Plus Dexamethasone (Arm B) in Participants With Relapsed/Refractory Multiple Myeloma (RRMM)Who this might be right forMultiple Myeloma GlaxoSmithKline 153
Testing effectiveness (Phase 2)UnknownNCT03975907What this trial is testingClinical Trial to Evaluate CT053 in Patients With Relapsed and/or Refractory Multiple Myeloma (LUMMICAR STUDY 1)Who this might be right forMultiple Myeloma CARsgen Therapeutics Co., Ltd. 121
Early research (Phase 1)UnknownNCT04309084What this trial is testingNatural Killer Cell (CYNK-001) Infusions in Adults With Multiple MyelomaWho this might be right forMultiple MyelomaNeoplasm, Plasma CellNeoplasms by Histologic Type+17 more Celularity Incorporated 29
Early research (Phase 1)Study completedNCT00400556What this trial is testingATRA Plus G-CSF for Mobilization of Hematopoietic Stem and Progenitor CellsWho this might be right forMultiple MyelomaCutaneous Lymphoma Peter MacCallum Cancer Centre, Australia 6
Large-scale testing (Phase 3)Active Not RecruitingNCT00098475What this trial is testingLenalidomide and Dexamethasone With or Without Thalidomide in Treating Patients With Multiple MyelomaWho this might be right forDS Stage I Multiple MyelomaDS Stage II Multiple MyelomaDS Stage III Multiple Myeloma National Cancer Institute (NCI) 452
Early research (Phase 1)Study completedNCT02468687What this trial is testingNMP in Relapsed / Refractory MyelomaWho this might be right forMultiple Myeloma Peter MacCallum Cancer Centre, Australia 13
Testing effectiveness (Phase 2)Study completedNCT00795769What this trial is testingOndansetron in Preventing Nausea and Vomiting in Patients Undergoing Stem Cell TransplantWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+101 more Fred Hutchinson Cancer Center 49